These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 32120468)

  • 21. Calcium signaling regulates trafficking of familial hypocalciuric hypercalcemia (FHH) mutants of the calcium sensing receptor.
    Grant MP; Stepanchick A; Breitwieser GE
    Mol Endocrinol; 2012 Dec; 26(12):2081-91. PubMed ID: 23077345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heterozygous inactivating CaSR mutations causing neonatal hyperparathyroidism: function, inheritance and phenotype.
    Glaudo M; Letz S; Quinkler M; Bogner U; Elbelt U; Strasburger CJ; Schnabel D; Lankes E; Scheel S; Feldkamp J; Haag C; Schulze E; Frank-Raue K; Raue F; Mayr B; Schöfl C
    Eur J Endocrinol; 2016 Nov; 175(5):421-31. PubMed ID: 27666534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generation of an induced pluripotent stem cell line HPCASRi002-A from a patient with neonatal severe primary hyperparathyroidism caused by a compound heterozygous mutation in the CASR gene.
    Panova AV; Kulikova KS; Klementieva NV; Krylov ID; Snezhko IO; Tiulpakov AN; Kiselev SL
    Stem Cell Res; 2021 Jul; 54():102414. PubMed ID: 34111698
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic defects associated with familial and sporadic hyperparathyroidism.
    Hendy GN; Cole DE
    Front Horm Res; 2013; 41():149-65. PubMed ID: 23652676
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary hyperparathyroidism in a patient with familial hypocalciuric hypercalcaemia due to a novel mutation in the calcium-sensing receptor gene.
    Egan AM; Ryan J; Aziz MA; O'Dwyer TP; Byrne MM
    J Bone Miner Metab; 2013 Jul; 31(4):477-80. PubMed ID: 23081733
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful use of cinacalcet monotherapy in the management of siblings with homozygous calcium-sensing receptor mutation.
    Wade L; Aindow A; Isherwood L; Mughal MZ; Ramakrishnan R
    J Pediatr Endocrinol Metab; 2022 Apr; 35(4):549-556. PubMed ID: 35073615
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cinacalcet therapy in an infant with an R185Q calcium-sensing receptor mutation causing hyperparathyroidism: a case report and review of the literature.
    Forman TE; Niemi AK; Prahalad P; Shi RZ; Nally LM
    J Pediatr Endocrinol Metab; 2019 Mar; 32(3):305-310. PubMed ID: 30730839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neonatal severe hyperparathyroidism caused by homozygous mutation in CASR: A rare cause of life-threatening hypercalcemia.
    Murphy H; Patrick J; Báez-Irizarry E; Lacassie Y; Gómez R; Vargas A; Barkemeyer B; Kanotra S; Zambrano RM
    Eur J Med Genet; 2016 Apr; 59(4):227-31. PubMed ID: 26855056
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel mutation of the calcium sensing receptor gene in familial hypocalciuric hypercalcaemia and neonatal severe hyperparathyroidism.
    de Andrade SC; Kohara SK; D'Souza-Li L
    Clin Endocrinol (Oxf); 2006 Dec; 65(6):826-7. PubMed ID: 17121537
    [No Abstract]   [Full Text] [Related]  

  • 30. A novel mutation of the calcium-sensing receptor gene in a German subject with familial hypocalciuric hypercalcemia and primary hyperparathyroidism.
    Papadakis M; Meurer N; Margariti T; Meyer A; Weyerbrock N; Dotzenrath C
    Hormones (Athens); 2016 Oct; 15(4):557-559. PubMed ID: 28222409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypercalcaemic and hypocalcaemic conditions due to calcium-sensing receptor mutations.
    Egbuna OI; Brown EM
    Best Pract Res Clin Rheumatol; 2008 Mar; 22(1):129-48. PubMed ID: 18328986
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of nephrolithiasis in primary hyperparathyroidism is associated with two polymorphisms of the calcium-sensing receptor gene.
    Vezzoli G; Scillitani A; Corbetta S; Terranegra A; Dogliotti E; Guarnieri V; Arcidiacono T; Macrina L; Mingione A; Brasacchio C; Eller-Vainicher C; Cusi D; Spada A; Cole DE; Hendy GN; Spotti D; Soldati L
    J Nephrol; 2015 Feb; 28(1):67-72. PubMed ID: 24832896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular pathogenesis of primary hyperparathyroidism.
    Cetani F; Pardi E; Borsari S; Marcocci C
    J Endocrinol Invest; 2011 Jul; 34(7 Suppl):35-9. PubMed ID: 21985978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical and genetic analysis of a child with neonatal severe parathyroidism].
    Dong Q; Song F; Du M; Qiu M; Chen X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Nov; 37(11):1247-1249. PubMed ID: 33179231
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Neonatal hyperparathyroidism].
    Nakagawa Y
    Nihon Rinsho; 2006 Jun; Suppl 2():20-2. PubMed ID: 16817341
    [No Abstract]   [Full Text] [Related]  

  • 36. Neonatal severe hyperparathyroidism due to compound heterozygous mutation of calcium sensing receptor (CaSR) gene presenting as encephalopathy.
    Kulkarni A; Mohite M; Vijaykumar R; Bansode P; Murade S; Tamhankar PM
    Indian J Pediatr; 2014 Nov; 81(11):1228-9. PubMed ID: 24763815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel homozygous deletion in the calcium-sensing receptor ligand-binding domain associated with neonatal severe hyperparathyroidism.
    Ward BK; Cameron FJ; Magno AL; McDonnell CM; Stuckey BG; Ratajczak T
    J Pediatr Endocrinol Metab; 2006 Jan; 19(1):93-100. PubMed ID: 16509534
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Calcium of 28mg/dL in patient of 4 days of life. Urgent treatment and follow-up.
    Segura González M; Carrasco Hidalgo-Barquero MC; Hidalgo-Barquero Del Rosal E
    Nefrologia (Engl Ed); 2019; 39(5):552-554. PubMed ID: 30857752
    [No Abstract]   [Full Text] [Related]  

  • 39. Primary hyperparathyroidism in neonates and childhood. The French experience (1984-2004).
    Mallet E;
    Horm Res; 2008; 69(3):180-8. PubMed ID: 18219222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Skeletal consequences of familial hypocalciuric hypercalcaemia vs. primary hyperparathyroidism.
    Christensen SE; Nissen PH; Vestergaard P; Heickendorff L; Rejnmark L; Brixen K; Mosekilde L
    Clin Endocrinol (Oxf); 2009 Dec; 71(6):798-807. PubMed ID: 19250271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.